Transdermal Patches
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method. A wide variety of pharmaceuticals are now available in transdermal patch form.
The first commercially available prescription patch was approved by the U.S. Food and Drug Administration in December 1979. These patches administered scopolamine for motion sickness.
Read more about Transdermal Patches: Development, Popular Uses, Adverse Events, Components, Regulatory Aspects, See Also
Famous quotes containing the word patches:
“A good story is one that isn’t demanding, that proceeds from A to B, and above all doesn’t remind us of the bad times, the cardboard patches we used to wear in our shoes, the failed farms, the way people you love just up and die. It tells us instead that hard work and perseverance can overcome all obstacles; it tells lie after lie, and the happy ending is the happiest lie of all.”
—Kathleen Norris (b. 1947)